← Leaderboards
Chi V. Dang
Johns Hopkins University
$24,535,395
Attributed
$25,933,360
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$65,136,100 · 11
By mechanism
P30$44,339,409 · 4
R01$16,411,349 · 3
R37$2,843,549 · 1
T32$1,335,293 · 1
G13$198,000 · 1
R13$8,500 · 1
Top collaborators
- Ben Z Stanger6 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Kristine Glunde$12,806,818
- Edward M Hedgecock$3,205,456
- Peter Cm Van Zijl$39,753,414
- Peter C Agre$14,013,185
- Nathan E Crone$16,249,944
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsProgramsTumorAreaInnovationTranslationsFosteringMemberCancer Center Support GrantCancer CenterIn VivoResource SharingTranslational ResearchCellsMetabolicMolecularCancer CellGrantGene ExpressionFundingPilot ProjectsResourcesCollaborationsIn Vitro
Grant awards (95)
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment$557,401
R01 · FY2025 · CA · contact PI
Defining the Role of the Cancer Circadian Clock in Tumor Immunity and Tumorigenesis$331,594
R01 · FY2025 · CA · contact PI
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment$529,533
R01 · FY2024 · CA · contact PI
Defining the Role of the Cancer Circadian Clock in Tumor Immunity and Tumorigenesis$315,014
R01 · FY2024 · CA · contact PI
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment$544,659
R01 · FY2023 · CA · contact PI
Defining the Role of the Cancer Circadian Clock in Tumor Immunity and Tumorigenesis$331,594
R01 · FY2023 · CA · contact PI
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment$462,168
R01 · FY2022 · CA · contact PI
Defining the Role of the Cancer Circadian Clock in Tumor Immunity and Tumorigenesis$363,222
R01 · FY2022 · CA · contact PI
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment$103,503
R01 · FY2022 · CA · contact PI
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment$598,666
R01 · FY2021 · CA · contact PI
Defining the Role of the Cancer Circadian Clock in Tumor Immunity and Tumorigenesis$370,636
R01 · FY2021 · CA · contact PI
c-Myc Targets in the Pathogenesis of Human Cancers$275,100
R01 · FY2021 · CA · contact PI
c-Myc Targets in the Pathogenesis of Human Cancers$225,384
R01 · FY2021 · CA · contact PI
c-Myc Targets in the Pathogenesis of Human Cancers$536,384
R01 · FY2020 · CA · contact PI
c-Myc Targets in the Pathogenesis of Human Cancers$229,065
R01 · FY2019 · CA · contact PI
ADMINISTRATION (Admin Core)$7,211
P30 · FY2019 · CA · contact PI
DEVELOPMENTAL FUNDS (Core 002)$7,211
P30 · FY2019 · CA · contact PI
PLANNING AND EVALUATION (Core 001)$7,211
P30 · FY2019 · CA · contact PI
ADMINISTRATION (Admin Core)$5,767
P30 · FY2019 · CA · contact PI
PLANNING AND EVALUATION (Core 001)$5,767
P30 · FY2019 · CA · contact PI
DEVELOPMENTAL FUNDS (Core 002)$5,767
P30 · FY2019 · CA · contact PI
PLANNING AND EVALUATION (Core 001)$3,626
P30 · FY2019 · CA · contact PI
DEVELOPMENTAL FUNDS (Core 002)$3,626
P30 · FY2019 · CA · contact PI
ADMINISTRATION (Admin Core)$3,625
P30 · FY2019 · CA · contact PI
DEVELOPMENTAL FUNDS (Core 002)$1,106
P30 · FY2019 · CA · contact PI
PLANNING AND EVALUATION (Core 001)$1,106
P30 · FY2019 · CA · contact PI
ADMINISTRATION (Admin Core)$1,105
P30 · FY2019 · CA · contact PI
c-Myc Targets in the Pathogenesis of Human Cancers$549,764
R01 · FY2018 · CA · contact PI
Myc - Transcription and Apoptosis$382,892
R01 · FY2018 · CA · contact PI
ADMINISTRATION (Admin Core)$9,406
P30 · FY2018 · CA · contact PI
DEVELOPMENTAL FUNDS (Core 002)$9,404
P30 · FY2018 · CA · contact PI
PLANNING AND EVALUATION (Core 001)$9,404
P30 · FY2018 · CA · contact PI
ADMINISTRATION (Admin Core)$1,472,509
P30 · FY2017 · CA · contact PI
DEVELOPMENTAL FUNDS (Core 002)$998,525
P30 · FY2017 · CA · contact PI
Myc - Transcription and Apoptosis$350,375
R01 · FY2017 · CA · contact PI
C MYC Targets in the Pathogenesis of Human Cancers$282,205
R01 · FY2017 · CA · contact PI
c-Myc Targets in the Pathogenesis of Human Cancers$248,583
R01 · FY2017 · CA · contact PI
Abramson Cancer Center Support Grant$125,000
P30 · FY2017 · CA · contact PI
PLANNING AND EVALUATION (Core 001)$52,873
P30 · FY2017 · CA · contact PI
MYC--Transcription and Apoptosis$27,000
R01 · FY2017 · CA · contact PI
Abramson Cancer Center Support Grant$7,975,543
P30 · FY2016 · CA · contact PI
ADMINISTRATION (Admin Core)$1,483,435
P30 · FY2016 · CA · contact PI
DEVELOPMENTAL FUNDS (Core 002)$995,265
P30 · FY2016 · CA · contact PI
MYC--Transcription and Apoptosis$733,273
R01 · FY2016 · CA · contact PI
Abramson Cancer Center Support Grant$499,967
P30 · FY2016 · CA · contact PI
Abramson Cancer Center Support Grant$200,000
P30 · FY2016 · CA · contact PI
PLANNING AND EVALUATION (Core 001)$52,720
P30 · FY2016 · CA · contact PI
Abramson Cancer Center Support Grant$31,250
P30 · FY2016 · CA · contact PI
Abramson Cancer Center Support Grant$7,704,373
P30 · FY2015 · CA · contact PI
MYC--Transcription and Apoptosis$394,000
R01 · FY2015 · CA · contact PI
Abramson Cancer Center Support Grant$125,000
P30 · FY2015 · CA · contact PI
Abramson Cancer Center Support Grant$62,498
P30 · FY2015 · CA · contact PI
Abramson Cancer Center Support Grant$7,449,701
P30 · FY2014 · CA · contact PI
MYC--Transcription and Apoptosis$456,800
R01 · FY2014 · CA · contact PI
C MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS$414,098
R01 · FY2014 · CA · contact PI
Abramson Cancer Center Support Grant$74,997
P30 · FY2014 · CA · contact PI
Abramson Cancer Center Support Grant$7,216,850
P30 · FY2013 · CA · contact PI
C MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS$401,292
R01 · FY2013 · CA · contact PI
Abramson Cancer Center Support Grant$12,499
P30 · FY2013 · CA · contact PI
Abramson Cancer Center Support Grant$7,725,062
P30 · FY2012 · CA · contact PI
C MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS$441,905
R01 · FY2012 · CA · contact PI
C MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS$436,955
R01 · FY2011 · CA · contact PI
C MYC--Transcription and Apoptosis$268,659
R01 · FY2011 · CA · contact PI
C MYC--Transcription and Apoptosis$21,707
R01 · FY2011 · CA · contact PI
C MYC--Transcription and Apoptosis$306,270
R01 · FY2010 · CA · contact PI
C MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS$200,208
R01 · FY2010 · CA · contact PI
C-MYC Targets in the Pathogenesis of Human Cancer$409,872
R01 · FY2009 · CA · contact PI
C MYC--Transcription and Apoptosis$306,270
R01 · FY2009 · CA · contact PI
C-MYC Targets in the Pathogenesis of Human Cancer$388,754
R01 · FY2008 · CA · contact PI
C MYC--Transcription and Apoptosis$306,270
R01 · FY2008 · CA · contact PI
C-MYC Targets in the Pathogenesis of Human Cancer$387,668
R01 · FY2007 · CA · contact PI
C MYC--Transcription and Apoptosis$439,059
R37 · FY2006 · CA · contact PI
C-MYC Targets in the Pathogenesis of Human Cancer$398,025
R01 · FY2006 · CA · contact PI
C MYC--Transcription and Apoptosis$449,625
R37 · FY2005 · CA
C-MYC Targets in the Pathogenesis of Human Cancer$407,500
R01 · FY2005 · CA
Training Program in Hematology$233,340
T32 · FY2005 · HL
C MYC--Transcription and Apoptosis$449,625
R37 · FY2004 · CA
C MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS$447,516
R01 · FY2004 · CA
Training Program in Hematology$232,640
T32 · FY2004 · HL
C MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS$434,482
R01 · FY2003 · CA
C MYC--TRANSCRIPTION AND APOPTOSIS$388,896
R37 · FY2003 · CA
Training Program in Hematology$222,168
T32 · FY2003 · HL
MYC Oncogene Hubsite$66,000
G13 · FY2003 · LM
C MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS$421,830
R01 · FY2002 · CA
C MYC--TRANSCRIPTION AND APOPTOSIS$380,076
R37 · FY2002 · CA
TRAINING PROGRAM IN HEMATOLOGY$190,326
T32 · FY2002 · HL
MYC Oncogene Hubsite$66,000
G13 · FY2002 · LM
C MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS$409,541
R01 · FY2001 · CA
C MYC--TRANSCRIPTION AND APOPTOSIS$371,979
R37 · FY2001 · CA
TRAINING PROGRAM IN HEMATOLOGY$247,199
T32 · FY2001 · HL
MYC Oncogene Hubsite$66,000
G13 · FY2001 · LM
FASEB conference on Hematological Malignancies$8,500
R13 · FY2001 · CA
C MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS$403,712
R01 · FY2000 · CA
C MYC--TRANSCRIPTION AND APOPTOSIS$364,289
R37 · FY2000 · CA
TRAINING PROGRAM IN HEMATOLOGY$209,620
T32 · FY2000 · HL